3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
10
Wilms Tumor
9
Leukemia, Myeloid, Acute
9
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Multiple Myeloma
8
Lung Neoplasms
8
Glioma
8
Sarcoma
7
Rhabdoid Tumor
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Carcinoma, Hepatocellular
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Myelodysplastic Syndromes
6
Medulloblastoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Central Nervous System Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
X-Rays
×
90 days
×
Clear all
No trials found.